Adverse Effects of Medications on Micronutrient Status: From Evidence to Guidelines.

Annual Review of Nutrition
Michael S DanielsDiane L McKay

Abstract

Recent dietary reference intake workshops focusing on nutrient requirements in chronic disease populations have called attention to the potential adverse effects of chronic medication use on micronutrient status. Although this topic is mostly ill defined in the literature, several noteworthy drug-nutrient interactions (DNIs) are of clinical and public health significance. The purpose of this narrative review is to showcase classic examples of DNIs and their impact on micronutrient status, including those related to antidiabetic, anticoagulant, antihypertensive, antirheumatic, and gastric acid-suppressing medications. Purported DNIs related to other drug families, while relevant and worthy of discussion, are not included. Unlike previous publications, this review is primarily focused on DNIs that have sufficient evidence supporting their inclusion in US Food and Drug Administration labeling materials and/or professional guidelines. While the evidence is compelling, more high-quality research is needed to establish clear and quantitative relationships between chronic medication use and micronutrient status.

References

Mar 13, 1998·JAMA : the Journal of the American Medical Association·E M HylekD E Singer
Aug 17, 1999·Archives of Internal Medicine·P J CaraballoL J Melton
Apr 3, 2002·Journal of Clinical Epidemiology·Fernie J A Penning-van BeestBruno H C Stricker
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
May 22, 2003·JAMA : the Journal of the American Medical Association·Bruce M PsatyNoel S Weiss
Oct 13, 2006·Archives of Internal Medicine·Rose Zhao-Wei TingKai Ming Chow
Nov 23, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M J BollandI R Reid
Aug 2, 2007·Journal of Thrombosis and Haemostasis : JTH·E K RomboutsF J M Van Der Meer
Nov 13, 2007·Journal of the American College of Cardiology·Akshay S DesaiUNKNOWN CHARM Program Investigators
Jan 16, 2008·Alimentary Pharmacology & Therapeutics·W P J den ElzenJ Gussekloo
Feb 26, 2008·Journal of the American Medical Directors Association·T S DharmarajanEdward P Norkus
Apr 2, 2008·The New England Journal of Medicine·Nigel S BeckettUNKNOWN HYVET Study Group
Apr 22, 2008·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S M OttK Wu
Feb 12, 2009·The Journal of Rheumatology·Mark C Fisher, Bruce N Cronstein
Apr 13, 2011·The American Journal of Gastroenterology·Saowanee NgamruengphongKenneth Nugent
May 19, 2011·JAMA : the Journal of the American Medical Association·Jean-Paul GalmicheUNKNOWN LOTUS Trial Collaborators
May 25, 2011·The American Journal of Medicine·Elaine W YuDouglas C Bauer
Jun 28, 2011·European Journal of Gastroenterology & Hepatology·Xiaofei YeJia He

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
I GauthierS Aronovitch
Journal of the American Dietetic Association
C W LewisD A Roe
American Journal of Otolaryngology
Niccolo' FavarettoGino Marioni
© 2021 Meta ULC. All rights reserved